Antitumor effect of XCT790, an ERRα inverse agonist, on ERα-negative endometrial cancer cells

Tetsuya Kokabu(Kyoto Prefectural University of Medicine), Jo Kitawaki(Kyoto Prefectural University of Medicine)

Cellular Oncology

January 31, 2019

10.1007/s13402-019-00423-5

Cited by 14

Related Papers

Estrogen-related receptor alpha induces epithelial-mesenchymal transition through cancer-stromal interactions in endometrial cancer

|Scientific Reports|2019|50

Anti-tumor effect of estrogen-related receptor alpha knockdown on uterine endometrial cancer

|Oncotarget|2016|44

Loss of AF-6/afadin induces cell invasion, suppresses the formation of glandular structures and might be a predictive marker of resistance to chemotherapy in endometrial cancer

|BMC Cancer|2015|33

Genistein induces long-term expression of progesterone receptor regardless of estrogen receptor status and improves the prognosis of endometrial cancer patients

|Scientific Reports|2022|18

Equilin in conjugated equine estrogen increases monocyte-endothelial adhesion via NF-κB signaling

|PLoS ONE|2019|5